Literature DB >> 1605169

Case report: venous thromboembolism in AIDS.

D M Becker1, T J Saunders, B Wispelwey, D C Schain.   

Abstract

Recently, the authors managed three patients with AIDS and venous thromboembolism. All three were active, ambulatory, and without known risk factors for pulmonary embolism or deep venous thrombosis. One patient had a low titer for IgG anticardiolipin antibody (1:13). Two had low normal values for free protein S, and the third patient had a very low value (5%). Clinicians caring for AIDS patients should be alert to the possibility that venous thromboembolism may complicate HIV infection.

Entities:  

Mesh:

Year:  1992        PMID: 1605169     DOI: 10.1097/00000441-199206000-00008

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

Review 1.  Antiphospholipid antibodies and infections.

Authors:  R A Asherson; R Cervera
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

Review 2.  Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.

Authors:  R Cervera; R A Asherson; M L Acevedo; J A Gómez-Puerta; G Espinosa; G De La Red; V Gil; M Ramos-Casals; M García-Carrasco; M Ingelmo; J Font
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

Review 3.  Review: thromboses among HIV-infected patients during the highly active antiretroviral therapy era.

Authors:  Nancy F Crum-Cianflone; Jhamillia Weekes; Mary Bavaro
Journal:  AIDS Patient Care STDS       Date:  2008-10       Impact factor: 5.078

4.  Acute pulmonary embolism in patients with HIV disease.

Authors:  S J Howling; P J Shaw; R F Miller
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

5.  Inferior vena cava filters for HIV infected patients with pulmonary embolism and contraindications to anticoagulation.

Authors:  M Shahmanesh; J Brooks; P J Shaw; R F Miller
Journal:  Sex Transm Infect       Date:  2000-10       Impact factor: 3.519

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.